Despite being marketed as an anti-anxiety treatment, CBD has not been proven to have any specific effect on anxiety. However, it has been shown to improve some symptoms related to mood disorders, including depression and sleep. It may also help ease side effects of certain cancer treatments, such as nausea and vomiting.

Research is ongoing to understand if CBD Luxe could be used as an add-on therapy for other mental health conditions. It has been suggested that cbd could help reduce social anxiety disorders, schizophrenia and non-motor symptoms associated with Parkinson’s disease. It is also being investigated as a possible treatment for substance misuse and other health conditions, such as insomnia.

A review of RWE suggests that CBD may have a positive impact on pain, anxiety and depression symptoms in people with chronic inflammatory or neurodegenerative diseases. This could be due to its anti-inflammatory properties and ability to modulate the activity of certain receptors.

CBD Myths vs. Facts: Separating Truth from Fiction in the Cannabidiol World

However, there are several limitations that need to be considered when evaluating the role of CBD in RWE. Specifically, the sample sizes of RWE studies are often small and do not reflect the general population. Furthermore, the collection of accurate product information is challenging, especially for inhaled CBD products.

Further, the quality of CBD in RWE is variable and has not been evaluated for safety or efficacy. It is important that consumers only use CBD derived from medical cannabis and have access to third-party lab test results for confirmation of the purity and potency of the product they are purchasing.